cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Evolus Inc
7 own
6 watching
Current Price
$9.75
$-0.87
(-8.19%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
547.79M
52-Week High
52-Week High
14.34
52-Week Low
52-Week Low
6.51
Average Volume
Average Volume
0.8M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization547.79M
icon52-Week High14.34
icon52-Week Low6.51
iconAverage Volume0.8M
iconDividend Yield--
iconP/E Ratio--
What does the Evolus Inc do?
N/A
Read More
How much money does Evolus Inc make?
News & Events about Evolus Inc.
Business Wire
3days ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in the SVB Securities Global Biopharma Conference. Event: SVB Securities Global Biopharma...
Business Wire
6days ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today presented interim data from its Phase II clinical study evaluating an 'extra-strength' formulation for extended duration of Jeuveau...
Business Wire
11days ago
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that the Australian Therapeutic Goods Administration (TGA) has provided regulatory approval for Nuceiva (prabotulinumtoxinA), a neurotoxin...
Ticker Report
12days ago
Evolus (NASDAQ:EOLS Get Rating) had its target price hoisted by SVB Leerink from $18.00 to $20.00 in a research note published on Thursday morning, Benzinga reports. They currently have an outperform rating on the stock. A number of other brokerages also recently weighed in on EOLS. Mizuho ...
Zolmax
12days ago
Evolus (NASDAQ:EOLS Get Rating) had its price target hoisted by Mizuho from $15.00 to $17.00 in a research report report published on Thursday, The Fly reports. They currently have a buy rating on the stock. Separately, HC Wainwright restated a buy rating on shares of Evolus in a report on Wednesday...
Frequently Asked Questions
Frequently Asked Questions
What is Evolus Inc share price today?
plus_minus_icon
Can Indians buy Evolus Inc shares?
plus_minus_icon
How can I buy Evolus Inc shares from India?
plus_minus_icon
Can Fractional shares of Evolus Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Evolus Inc stocks?
plus_minus_icon
What is today’s traded volume of Evolus Inc?
plus_minus_icon
What is today’s market capitalisation of Evolus Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Evolus Inc?
plus_minus_icon
What percentage is Evolus Inc down from its 52-Week High?
plus_minus_icon
What percentage is Evolus Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$9.75
$-0.87
(-8.19%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00